ACADIA PHARMACEUTICALS INC. Noncash or Part Noncash Acquisition, Fixed Assets Acquired
ACADIA PHARMACEUTICALS INC. (ACAD) reported Noncash or Part Noncash Acquisition, Fixed Assets Acquired of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 · last filed 2026-02-26
- ACADIA PHARMACEUTICALS INC. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- ACADIA PHARMACEUTICALS INC. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2025-09-30 was $0.00.
- ACADIA PHARMACEUTICALS INC. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2025-06-30 was $0.00.
- ACADIA PHARMACEUTICALS INC. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- ACADIA PHARMACEUTICALS INC. noncash or part noncash acquisition, fixed assets acquired for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- ACADIA PHARMACEUTICALS INC. noncash or part noncash acquisition, fixed assets acquired for fiscal 2024 was $98.84M, a 234.10% increase from fiscal 2023.
- ACADIA PHARMACEUTICALS INC. noncash or part noncash acquisition, fixed assets acquired for fiscal 2023 was $29.58M.
- ACADIA PHARMACEUTICALS INC. noncash or part noncash acquisition, fixed assets acquired for fiscal 2022 was $0.00.
| Period end | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 3 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 6 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 9 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | $48.84M derived: sum of 4 quarters · filed 2026-02-26 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | $48.84M derived: sum of 3 quarters · filed 2026-02-26 | $48.84M derived: sum of 4 quarters · filed 2026-02-26 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | $48.84M derived: sum of 2 quarters · filed 2026-02-26 | $48.84M derived: sum of 3 quarters · filed 2026-02-26 | $48.84M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-12-31 | $48.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $48.84M derived: sum of 2 quarters · filed 2026-02-26 | $48.84M derived: sum of 3 quarters · filed 2026-02-26 | $98.84M 10-K · filed 2026-02-26 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $50.00M 10-Q · filed 2025-11-06 | $50.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $50.00M 10-Q · filed 2025-08-07 | $50.00M derived: sum of 3 quarters · filed 2026-02-26 | $50.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $50.00M 10-Q · filed 2025-05-08 | $50.00M derived: sum of 2 quarters · filed 2026-02-26 | $50.00M derived: sum of 3 quarters · filed 2026-02-26 | $10.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | -$40.00M derived: sum of 3 quarters · filed 2026-02-26 | $29.58M 10-K · filed 2026-02-26 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$40.00M derived: sum of 2 quarters · filed 2024-11-07 | $29.58M 10-Q · filed 2024-11-07 | $29.58M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$40.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $29.58M 10-Q · filed 2024-08-07 | $29.58M derived: sum of 3 quarters · filed 2025-02-27 | $29.58M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $69.58M 10-Q · filed 2024-05-09 | $69.58M derived: sum of 2 quarters · filed 2025-02-27 | $69.58M derived: sum of 3 quarters · filed 2025-02-27 | $69.58M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $0.00 derived: sum of 3 quarters · filed 2025-02-27 | $0.00 10-K · filed 2025-02-27 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $0.00 derived: sum of 2 quarters · filed 2023-11-03 | $0.00 10-Q · filed 2023-11-03 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $0.00 10-Q · filed 2023-08-03 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-08 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-28 | |||
| 2021-03-31 | $45.00K 10-Q · filed 2022-05-05 | -$751.00K derived: sum of 2 quarters · filed 2023-02-28 | -$113.00K derived: sum of 3 quarters · filed 2023-02-28 | -$1.09M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$796.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$158.00K derived: sum of 2 quarters · filed 2023-02-28 | -$1.14M derived: sum of 3 quarters · filed 2023-02-28 | $130.00K 10-K · filed 2023-02-28 |
| 2020-09-30 | $638.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$343.00K derived: sum of 2 quarters · filed 2021-11-09 | $926.00K 10-Q · filed 2021-11-09 | $919.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$981.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $288.00K 10-Q · filed 2021-08-05 | $281.00K derived: sum of 3 quarters · filed 2022-03-01 | $305.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $1.27M 10-Q · filed 2021-05-06 | $1.26M derived: sum of 2 quarters · filed 2022-03-01 | $1.29M derived: sum of 3 quarters · filed 2022-03-01 | $1.28M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | -$7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $17.00K derived: sum of 2 quarters · filed 2022-03-01 | $13.00K derived: sum of 3 quarters · filed 2022-03-01 | $34.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | $24.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $20.00K derived: sum of 2 quarters · filed 2020-11-04 | $41.00K 10-Q · filed 2020-11-04 | -$79.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | -$4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $17.00K 10-Q · filed 2020-08-06 | -$103.00K derived: sum of 3 quarters · filed 2021-02-25 | -$124.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $21.00K 10-Q · filed 2020-05-08 | -$99.00K derived: sum of 2 quarters · filed 2021-02-25 | -$120.00K derived: sum of 3 quarters · filed 2021-02-25 | |
| 2018-12-31 | -$120.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$141.00K derived: sum of 2 quarters · filed 2021-02-25 | $160.00K 10-K · filed 2021-02-25 | |
| 2018-09-30 | -$21.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $280.00K 10-Q · filed 2019-10-31 | ||
| 2018-06-30 | $301.00K 10-Q · filed 2019-08-01 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$34.00K derived: sum of 2 quarters · filed 2020-02-27 | -$166.00K derived: sum of 3 quarters · filed 2020-02-27 | $9.00K 10-K · filed 2020-02-27 |
| 2017-09-30 | -$34.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$166.00K derived: sum of 2 quarters · filed 2018-11-06 | $9.00K 10-Q · filed 2018-11-06 | -$58.00K derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | -$132.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $43.00K 10-Q · filed 2018-08-08 | -$24.00K derived: sum of 3 quarters · filed 2019-02-27 | $9.00K derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $175.00K 10-Q · filed 2018-05-04 | $108.00K derived: sum of 2 quarters · filed 2019-02-27 | $141.00K derived: sum of 3 quarters · filed 2019-02-27 | $39.00K derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | -$67.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$34.00K derived: sum of 2 quarters · filed 2019-02-27 | -$136.00K derived: sum of 3 quarters · filed 2019-02-27 | $220.00K 10-K · filed 2019-02-27 |
| 2016-09-30 | $33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$69.00K derived: sum of 2 quarters · filed 2017-11-07 | $287.00K 10-Q · filed 2017-11-07 | $257.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | -$102.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $254.00K 10-Q · filed 2017-08-08 | $224.00K derived: sum of 3 quarters · filed 2018-02-27 | |
| 2016-03-31 | $356.00K 10-Q · filed 2017-05-09 | $326.00K derived: sum of 2 quarters · filed 2018-02-27 | ||
| 2015-12-31 | -$30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $156.00K 10-K · filed 2018-02-27 | ||
| 2015-09-30 | $186.00K 10-Q · filed 2016-11-07 | |||
| 2015-03-31 | $367.00K 10-Q · filed 2016-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |